American Samoa vs Myanmar: Treatment coverage for lymphatic filariasis
American Samoa
33.9%
in 2022
Myanmar
23.8%
in 2024
American Samoa rank
45th
Myanmar rank
48th
Treatment coverage for lymphatic filariasis over time
- American Samoa
- Myanmar
How they compare
American Samoa currently reports 33.9% against 23.8% in Myanmar, a difference of 10.1%.
That makes American Samoa's figure about 1.4 times Myanmar's.
The two have swapped places 4 times across 12 shared years of data; in 2001 it was American Samoa ahead.
American Samoa ranks 45th and Myanmar ranks 48th of 66 countries.
Across the 3 decades both report, American Samoa averaged higher in 2 and Myanmar in 1.
Head to head by decade
| Decade | American Samoa | Myanmar | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 41.5% | 23.6% | 17.9% | American Samoa |
| 2010s | 49.9% | 44.8% | 5.2% | American Samoa |
| 2020s | 11.3% | 34.7% | 23.4% | Myanmar |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher treatment coverage for lymphatic filariasis, American Samoa or Myanmar?
- American Samoa, at 33.9% against 23.8% in Myanmar as of 2022.
- What is the difference in treatment coverage for lymphatic filariasis between American Samoa and Myanmar?
- 10.1%, with American Samoa ahead.
- How many years of comparable data are there for American Samoa and Myanmar?
- 12 years are reported by both, from 2001 to 2022.
- How do American Samoa and Myanmar rank globally for treatment coverage for lymphatic filariasis?
- American Samoa ranks 45th and Myanmar ranks 48th of 66 countries.
- Where does this data come from?
- World Health Organization (2025) – with minor processing by Our World in Data, published as Treatment coverage for lymphatic filariasis. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Drug coverage out of estimated population who require it.